- $78.26m
- $226.26m
- $278.30m
- 41
- 65
- 16
- 35
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.12 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.28 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -74.86% | ||
| Return on Equity | -184.88% | ||
| Operating Margin | -65.57% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 186.89 | 267.12 | 298.54 | 309.2 | 278.3 | 272.78 | 294.49 | 5.75% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cardlytics, Inc. is a provider of a digital advertising platform. Through the Cardlytics platform, its financial media network, marketers deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States and the United Kingdom. Cardlytics platform helps marketers find new customers that are active in their category but not shopping with them, or to grow their business with existing customers. Cardlytics platform provides its marketers with a scalable solution for driving customer loyalty and engagement, whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting the performance of their campaigns to attributing incentives to each of its partners customers. The Bridg platform is a customer data platform that utilizes POS data from its merchant data partners, including product-level purchase data.
Directors
- Scott Grimes CHM (58)
- Lynne Laube CEO (51)
- Andrew Christiansen CFO (42)
- Kirk Somers CHO (55)
- Peter Chan CTO
- John Balen LED (60)
- Christopher Suh DRC (51)
- David Adams IND (64)
- Jessica Jensen IND (49)
- Mark Johnson IND (68)
- John Klinck IND (57)
- Aimee Lapic IND (51)
- Tony Weisman IND (61)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 26th, 2008
- Public Since
- February 9th, 2018
- No. of Shareholders
- 109
- No. of Employees
- 454
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Market- Shares in Issue
- 52,174,481
- Address
- 675 Ponce De Leon Avenue, Ne, Suite 4100, ATLANTA, 30308
- Web
- https://www.cardlytics.com/
- Phone
- +1 3026365400
- Auditors
- Deloitte & Touche LLP
Upcoming Events for CDLX
Cardlytics Inc Annual Shareholders Meeting
Cardlytics Inc Annual Shareholders Meeting
Q2 2025 Cardlytics Inc Earnings Release
Similar to CDLX
1stdibs.com
NASDAQ Global Market
Airship AI Holdings
NASDAQ Global Market
Alpha Modus Holdings
NASDAQ Global Market
AppFolio
NASDAQ Global Market
Appian
NASDAQ Global Market
FAQ
What is the Cardlytics share price?
As of Today at 19:48 UTC, shares in Cardlytics are trading at $1.50. This share price information is delayed by 15 minutes.
How has the Cardlytics share price performed this year?
Shares in Cardlytics last closed at $1.50 and the price had moved by -87.68% over the past 365 days. In terms of relative price strength the Cardlytics share price has underperformed the S&P500 Index by -88.42% over the past year.
What are the analyst and broker recommendations for Cardlytics?
The overall consensus recommendation for Cardlytics is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Cardlytics dividend yield?
Cardlytics does not currently pay a dividend.
Does Cardlytics pay a dividend?
Cardlytics does not currently pay a dividend.
When does Cardlytics next pay dividends?
Cardlytics does not currently pay a dividend.
How do I buy Cardlytics shares?
To buy shares in Cardlytics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cardlytics?
As of the previous close price of $1.50, shares in Cardlytics had a market capitalisation of $78.26m.
Where are Cardlytics shares listed?
Here are the trading details for Cardlytics:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: CDLX
What kind of share is Cardlytics?
Based on an overall assessment of its quality, value and momentum Cardlytics is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cardlytics share price forecast for 2025?
The analyst consensus target price for shares in Cardlytics is $3.30. That is 120% above the last closing price of $1.50.
Analysts covering Cardlytics currently have a consensus Earnings Per Share (EPS) forecast of -$0.43 for the next financial year.
Find out moreWhat is the trend in the Cardlytics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cardlytics. Over the past six months, its share price has underperformed the S&P500 Index by -58.18%.
As of the last closing price of $1.50, shares in Cardlytics were trading -61.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cardlytics PE Ratio?
The Cardlytics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cardlytics?
Cardlytics' management team is headed by:
- Scott Grimes - CHM
- Lynne Laube - CEO
- Andrew Christiansen - CFO
- Kirk Somers - CHO
- Peter Chan - CTO
- John Balen - LED
- Christopher Suh - DRC
- David Adams - IND
- Jessica Jensen - IND
- Mark Johnson - IND
- John Klinck - IND
- Aimee Lapic - IND
- Tony Weisman - IND